Search and Browse
Download
Enter Data
| Reaction Details | |||
|---|---|---|---|
 | Report a problem with these data | ||
| Target | Serine/threonine-protein kinase B-raf | ||
| Ligand | BDBM50303110 | ||
| Substrate/Competitor | n/a | ||
| Meas. Tech. | ChEMBL_597720 (CHEMBL1043507) | ||
| IC50 | 2±n/a nM | ||
| Citation |  Di Grandi, MJ; Berger, DM; Hopper, DW; Zhang, C; Dutia, M; Dunnick, AL; Torres, N; Levin, JI; Diamantidis, G; Zapf, CW; Bloom, JD; Hu, Y; Powell, D; Wojciechowicz, D; Collins, K; Frommer, E Novel pyrazolopyrimidines as highly potent B-Raf inhibitors. Bioorg Med Chem Lett19:6957-61 (2009) [PubMed] Article | ||
| More Info.: | Get all data from this article, Assay Method | ||
| Serine/threonine-protein kinase B-raf | |||
| Name: | Serine/threonine-protein kinase B-raf | ||
| Synonyms: | B-RAF | B-Raf Protein Kinase | B-Raf proto-oncogene serine/threonine-protein kinase | BRAF | BRAF1 | BRAF_HUMAN | RAFB1 | p94 | v-Raf murine sarcoma viral oncogene homolog B1 | ||
| Type: | Serine/threonine-protein kinase | ||
| Mol. Mass.: | 84446.00 | ||
| Organism: | Homo sapiens (Human) | ||
| Description: | P15056 | ||
| Residue: | 766 | ||
| Sequence: |
| ||
| BDBM50303110 | |||
| n/a | |||
| Name | BDBM50303110 | ||
| Synonyms: | CHEMBL585334 | ethyl 3-(3-(1H-indazol-4-yl)-2-(pyridin-4-yl)-1,2-dihydropyrazolo[1,5-a]pyrimidin-7-yl)-8-azabicyclo[3.2.1]octane-8-carboxylate | ||
| Type | Small organic molecule | ||
| Emp. Form. | C28H27N7O2 | ||
| Mol. Mass. | 493.5597 | ||
| SMILES | CCOC(=O)N1C2CCC1CC(C2)c1ccnc2c(c(nn12)-c1ccncc1)-c1cccc2[nH]ncc12 |THB:13:11:5:7.8,(16.08,-21.46,;14.76,-22.25,;13.41,-21.51,;12.09,-22.3,;10.75,-21.56,;12.12,-23.84,;11.59,-25.31,;10.07,-25.99,;11.44,-25.95,;12.63,-25.09,;14.17,-25.94,;13.63,-27.41,;13.18,-26.22,;13.63,-28.95,;12.3,-29.72,;12.3,-31.26,;13.63,-32.03,;14.97,-31.26,;16.44,-31.73,;17.35,-30.49,;16.44,-29.23,;14.97,-29.71,;18.88,-30.48,;19.65,-31.82,;21.19,-31.82,;21.96,-30.48,;21.18,-29.15,;19.65,-29.15,;16.51,-33.27,;15.21,-34.09,;15.27,-35.64,;16.63,-36.35,;17.94,-35.53,;19.43,-35.94,;20.29,-34.65,;19.32,-33.44,;17.87,-33.98,)| | ||
| Structure | 
| ||